Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Terrascend Corp (OP: TRSSF )

N/A UNCHANGED
Last Price Updated: 3:59 PM EDT, Jul 5, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Terrascend Corp

< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Analysts May Need To Revise Cannabis Stock Projections For 2024: 10 Companies Surpass EBITDA Estimates By $37M
Cannabis equity analysts may need to revise their 2024 earnings estimates after first-quarter results from major multi-state operators (MSOs). According to a recent report by Viridian Capital Advisors,... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: Analysts React Meekly To Strong Q1'24 Earnings
In our January 2024 outlook, we asserted that cannabis equity analysts, having been burned by the need for continual downward revisions in 2023, were undershooting in their 2024 & 2025 estimates. First... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
State-Run Vs. Private: Pennsylvania Debates Transition Of Liquor Store Model To Cannabis Distribution
The conversation around cannabis legalization in Pennsylvania is pivoting towards a potential state-run model, akin to the existing system for alcohol sales. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Who's Winning In Weed? Analyst Looks At Cannabis Market's Big Players, Where Are The Best Bets?
In the first quarter of 2024, the cannabis sector faces a mixed economic landscape with a notable sequential decline in sales across several states. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
4/20 Cannabis Retail Frenzy: Leading Brands Ready For Record Sales Surge - Who Will Lead?
This 4/20 cannabis retailers anticipate record-breaking sales fueled by last year's +130% spike and the fortunate alignment of this year's celebration falling on a Saturday. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: The Market Reacted Rationally (For A Change) To 4th Qtr 2023 Earnings Releases
Earnings for the 4th quarter of 2023 have largely been released, and the results were generally positive, with a few exceptions. Unlike what we expected, the market reacted rationally to the EBITDA... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Overweight Rating Highlights Jushi Holdings' Market Edge: Weed Stock Valuation Gap Analysis
Zuanic & Associates gave Jushi Holdings Inc. (CSE: JUSH) (OTC: JUSHF) an Overweight rating as the firm begins its coverage of the marijuana company. 
Via Benzinga
Jupiter Research Launches Weed Vape Cartridges With Custom Technology: Exploring The Top Company Fueling The Brand
TILT Holdings' (OTC: TLLTF) subsidiary, Jupiter Research, has launched THREDZ, a new 510 cartridge technology enabling users to blend two oil cartridges for customized cannabinoid and terpene... 
Via Benzinga
Fast Track Recap: Colorado & Michigan Weed Sales Decline, Virginia Eyes Legal Market, Stock Winners & Losers
Colorado's cannabis market, once a frontrunner in the U.S. for recreational marijuana sales, has experienced a downturn. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Triple Play: Tracking Booming Markets In Connecticut, Maryland And Maine For Investment Insights
Connecticut's Record Sales In December Connecticut experienced a record-breaking December in 2023, with combined sales of adult-use cannabis and medical marijuana surpassing $27.5 million. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tesla Investor Ross Gerber Calls On DEA To Reschedule Cannabis: 'Absurd We're Still Waiting'
It wasn’t long ago when Ross Gerber, president and CEO of Gerber Kawasaki Wealth and Investment Management and an enthusiastic Tesla Inc (NASDAQ: TSLA) 
Via Benzinga
Nuns Lose Fight Against Cannabis Shop 150 Feet From Convent As Atlantic City Aims To Be East Coast Weed Hub
Catholic nuns in Atlantic City, N.J. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Curaleaf's Strategic Move To Attract Deeper-Pocketed Investors, Internal Reorganization Sets Stage For TSX Listing
Curaleaf Holdings, Inc. announced an internal reorganization of its U.S. operations, related to receiving a conditional approval of the Toronto Stock Exchange to list the company's subordinate voting... 
Via Benzinga
Cannabis Chart Of The Week: Who Are The Strongest MSO Credits And How Are They Trending?
The Viridian Credit Tracker model is a valuable tool for investors and companies alike to gauge the credit quality of cannabis companies. The model utilizes 11 market-based and financial... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Tier 2 Cannabis Companies: Viridian Capital Advisors Analysis Reveals 'Attractive' Valuations For Public Companies
In a comprehensive report by Viridian Capital Advisors, the spotlight is on the valuations of companies within the U.S. cultivation and retail sector, specifically those boasting market caps ranging... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: Revenue And EBITDA Beats Are Great, But The Real Story Is Cash Flow From Operations
Third-quarter earnings releases still have about a week to go. Still, eight companies representing over 78% of the total market cap of the fourteen MSOs with market caps over $100M have reported and... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Market Turbulence: Why Analyst Says Tier-2 MSOs Were October's Bright Spot
October's cannabis market sharp declines and volatility, influenced by geopolitical events and legislative shifts. Dive in Roth MKM's report! 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: Most MSO Revenue Growth Is New Market Related
The Viridian Chart of the Week shows analyst estimates for MSO revenue for the third quarter of 2023 relative to the second quarter of 2023 and the third quarter of 2022. The green bars depict... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Which Is the Better Cannabis Growth Stock for You: Cresco Labs or TerrAscend?
Cannabis stocks are back in style, but is either one of these multi-state operators a long-term buy? 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
High Capex, High Rewards: Analyst Looks At Cannabis MSOs' Strategies
As interest rates climb and regulatory uncertainties loom, decisions on capital expenditures (capex) by cannabis MSOs (Multi-State Operators) become paramount for their future success. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
This Top Marijuana Stock Is Making a Big Move to a Major Exchange
Curaleaf could be the latest U.S. pot stock to hit the Toronto Stock Exchange. Will others follow? 
Via The Motley Fool
Topics Cannabis
Exposures Cannabis
Who's Who Among Cannabis Hardware & Vaping Suppliers? Zuanic & Associates Take A Deep Dive
Are you curious about the key players, their standings and the driving forces in the cannabis hardware and vaping sector? In this in-depth report, senior analyst Pablo Zuanic from Zuanic &... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
EXCLUSIVE: Why TerrAscend's Success Doesn't Rely On Federal Cannabis Reform
At a time when marijuana businesses are hoping for cannabis reform on the federal level, one company is no longer at the mercy of policymakers on the Hill. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Meet The Winners Of The 2023 Benzinga Cannabis Awards And Join The Chicago Conference Online
Winners of the second annual Benzinga Cannabis Awards were announced at the Benzinga Cannabis Capital Conference underway in Chicago on September 27-28.  
Via Benzinga
Topics Cannabis
Exposures Cannabis
Benzinga Cannabis Capital Conference Announces Awards Finalists
Finalists for the second annual Benzinga Cannabis Awards have been unveiled. This coveted recognition spotlights the cannabis industry's luminaries, from trailblazers and innovators to advocates who... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: How Much Run Is Left In MSO Valuation Multiples?
The MSOS ETF (ARCA: MSOS) gained 69.4% between 8/25/23, five days before the blockbuster announcement of an HHS rescheduling recommendation to this past Friday, 9/8/23. Similarly, the... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Major Capital Market Crisis In Cannabis Industry? Here's What TerrAscend's Jason Wild Says
"The environment is bad… The [cannabis] industry is truly in a major storm," said Jason Wild, executive chairman of TerrAscend Corp (OTC: TRSSF) at the Benzinga Cannabis Capital Confer 
Via Benzinga
Topics Cannabis
Exposures Cannabis
This US Cannabis Stock Is No Longer At The Mercy Of U.S. Regulations, Here's Why
At a time when many are giving up on investing in cannabis, Jason Wild, the executive chair of TerrAscend Corp. 
Via Benzinga
Topics Cannabis
Exposures Cannabis
Cannabis Chart Of The Week: Q2 EBITDAs Beat Estimates, But Full-Year Projections Tell A Different Story
Second quarter 2023 earnings releases are complete, and the results were fascinating. One of the things that makes us skeptical about these quarterly reports is the forceful steering that companies... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
TerrAscend Delighted About Maryland's Cannabis Sales, Meet Exec Chair Jason Wild At Benzinga Conference In Chicago
After Maryland’s cannabis users collectively spent a whopping $87.43 million on marijuana products during the state’s first full month of recreational sales, TerrAscend (OTCQX: 
Via Benzinga
Topics Cannabis
Exposures Cannabis
< Previous 1 2 3 4 5 6 7 8 9
...
16 17 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.